TE_38164
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | THE1A, L1HS_5end |
|---|---|
| TE superfamily | MaLR, L1 |
| TE order | LINE, LTR |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 499.87 |
| Counts of samples | TCGA_tumor:886; TCGA_normal:1; GTEx:0 |
| TSS | chrX(-):130573685 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_38164.1 | - | Intergenic | Non-coding | Non-coding | chrX(-):130528244,130528264,130566618,130566791,130573601,130573686 |
| teRNA_38164.2 | - | Intergenic | Non-coding | Non-coding | chrX(-):130565836,130565856,130566618,130566791,130573557,130573686 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
